Influence of the first wave of COVID-19 on asthma inhaler prescriptions
File(s)
Published version
Author(s)
Bloom, Chloe
Wong, Ernie
Hickman, Katharine
Elkin, Sarah
Type
Journal Article
Abstract
In the beginning of the COVID-19 pandemic there were major concerns regarding the huge demand for asthma inhalers. Using primary care medical records for 614,700 asthma patients between January and June 2020, we found that there was a substantial increase in inhalers solely in March 2020. Patients significantly associated with receiving higher inhaled corticosteroid prescriptions were younger, of higher socioeconomic status and had milder asthma.
Date Issued
2021-11-25
Date Acceptance
2021-11-03
Citation
npj Primary Care Respiratory Medicine, 2021, 31
ISSN
2055-1010
Publisher
Nature Research
Journal / Book Title
npj Primary Care Respiratory Medicine
Volume
31
Copyright Statement
© 2021 The Author(s) Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
License URL
Sponsor
Imperial College London
Identifier
https://www.nature.com/articles/s41533-021-00260-w
Subjects
Science & Technology
Life Sciences & Biomedicine
Primary Health Care
Respiratory System
General & Internal Medicine
Publication Status
Published
Date Publish Online
2021-11-25